IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9371294 B1

PDFFull Text
Date of Patent:
Jun. 21, 2016

Filed:

Apr. 12, 2012

Cycloalkenyl aryl derivatives for cetp inhibitor

Applicants:

Seohee Lee, Yongin-si, KR;

Jung Taek OH, Yongin-si, KR;

Jaekwang Lee, Yongin-si, KR;

Jaewon Lee, Yongin-si, KR;

Suyeal Bae, Yongin-si, KR;

Nina Ha, Yongin-si, KR;

Sera Lee, Yongin-si, KR;

Inventors:

SeoHee Lee, Yongin-si, KR;

Jung Taek Oh, Yongin-si, KR;

JaeKwang Lee, Yongin-si, KR;

JaeWon Lee, Yongin-si, KR;

Suyeal Bae, Yongin-si, KR;

Nina Ha, Yongin-si, KR;

Sera Lee, Yongin-si, KR;

Assignee:

CHONG KUN DANG PHARMACEUTICAL CORP., , KR;

Attorney:

Heslin, Rothenberg, Farley & Mesiti P.C.

Primary Examiner:

Kamal Saeed

Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 403/10 (2006.01); C07D 405/14 (2006.01); C07D 263/24 (2006.01); C07D 263/16 (2006.01); C07D 263/22 (2006.01); C07D 401/06 (2006.01); C07D 413/06 (2006.01); C07D 413/08 (2006.01); C07D 413/10 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 263/24 (2013.01); C07D 263/16 (2013.01); C07D 263/22 (2013.01); C07D 401/06 (2013.01); C07D 413/06 (2013.01); C07D 413/08 (2013.01); C07D 413/10 (2013.01); C07D 417/12 (2013.01);
Abstract

The present invention relates to cycloalkenyl aryl derivatives, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof, or solvates thereof; a method for preparing the derivatives; and pharmaceutical compositions containing the same. The compounds of the present invention show the effect of CETP activity inhibition. It means that the compounds can increase HDL-cholesterol and decrease LDL-cholesterol.

Find Patent Forward Citations

Loading…